Time course effect of hypoxia on bone marrow-derived endothelial progenitor cells and their effects on left ventricular function after transplanted into acute myocardial ischemia rat.
نویسندگان
چکیده
OBJECTIVE Ischemic heart disease is the most common cause of cardiovascular morbidity and mortality in the industrialized world, and the incidence has been increasing in developing countries. Stem cell transplantation has emerged as a potent new therapeutic strategy for acute/chronic ischemic heart disease and has been explored extensively. The present study aimed to investigate whether hypoxic preconditioning of endothelial progenitor cells (EPCs) before transplantation could ameliorate their survival and engraftment in ischemic tissue and the potential mechanisms. MATERIALS AND METHODS EPCs extracted were subjected to increasing hypoxia for 24-72 h, survival and function of the preconditioned EPCs were assayed in both in vitro and in vivo. RESULTS Hypoxia for 24 h caused significant enhancements in formation of tube like structure and motility of BM-EPCs (p < 0.05), as well as mRNA expressions of CXCR4, PI3K, AKT, and NF-κB, while these effects were reversed by prolonged hypoxia (48 and 72 h, p < 0.05). Hypoxia of BM-EPCs for 24 h did not result in increased apoptosis resistance, and cell apoptosis was even enhanced by prolonged hypoxia. In vivo transplantation experiments demonstrated the beneficial effect of hypoxic EPCs on left ventricular (LV) functions after acute myocardial ischemia (AMI). CONCLUSIONS Shorter-term hypoxia showed better survival, differentiation and function of BM-EPCs in vivo, further study was still needed to optimize the hypoxic pattern of BM-EPCs so as to better protect heart from myocardial ischemic injury. The present study showed evidence suggested that hypoxic preconditioning did exert further beneficial effects of BM-EPCs on preservation of LV function after AMI. Short-term exposure to hypoxia for about 24 h provided better condition for survival and function of BM-EPCs.
منابع مشابه
Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium.
RATIONALE Endothelial progenitor cell (EPC) survival and function in the injured myocardium is adversely influenced by hostile microenvironment such as ischemia, hypoxia, and inflammatory response, thereby compromising full benefits of EPC-mediated myocardial repair. OBJECTIVE We hypothesized that interleukin-10 (IL-10) modulates EPC biology leading to enhanced survival and function after tra...
متن کاملMesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model.
BACKGROUND Cellular cardiomyoplasty is a promising approach to improve postinfarcted cardiac function. The differentiation pathways of engrafted mesenchymal progenitor cells (MPCs) and their effects on the left ventricular function in a rat myocardial infarct heart model were analyzed. METHODS AND RESULTS A ligation model of left coronary artery of Lewis rats was used. MPCs were isolated by b...
متن کاملTransplantation of bone marrow-derived endothelial progenitor cells attenuates myocardial interstitial fibrosis and cardiac dysfunction in streptozotocin-induced diabetic rats.
Diabetic cardiomyopathy (DCM) is a progressive disease of the heart muscle and the third most common cause of heart failure. In the present study, we evaluated the effects of bone marrow‑derived endothelial progenitor cell (EPC) transplantation on the development of DCM in a streptozotocin (STZ)-induced diabetic rat model. Ex vivo generated, characterized and cultivated rat EPCs were identified...
متن کاملClinical trials using autologous bone marrow and peripheral blood-derived progenitor cells in patients with acute myocardial infarction.
This paper discusses the current data concerning the results of major clinical trials using bone marrow-derived and peripheral blood-derived stem/progenitor cells in treatment of patients with acute myocardial infarction (AMI) and depressed left ventricular ejection fraction. In all major trials (TOPCARE-AMI, BOOST), the primary outcome measure was increase in left ventricular systolic function...
متن کاملAre Stem Cells the next Therapeutic Tool for Heart Repair?
Cardiovascular disease remains the leading cause of morbidity and mortality in the United States and Europe. In recent years, the understanding that regenerative processes exist at the level of the myocardium, has placed stem cell research at center stage in cardiology. A stem cell is a cell that has the ability to divide (self replicate) for indefinite periods often throughout the life of the ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- European review for medical and pharmacological sciences
دوره 19 6 شماره
صفحات -
تاریخ انتشار 2015